Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection

144Citations
Citations of this article
46Readers
Mendeley users who have this article in their library.

Abstract

Chronic granulomatous disease (CGD) is characterized by life-threatening bacterial and fungal infections. Treatment with posaconazole led to a complete response in 7 of 8 patients with CGD with invasive mold infections (7 proven cases and 1 possible case) after failure or intolerance of treatment with standard antifungal agents. In this preliminary study, salvage treatment with posaconazole was safe and effective. © 2005 by the Infectious Diseases Society of America. All rights reserved.

Cite

CITATION STYLE

APA

Segal, B. H., Barnhart, L. A., Anderson, V. L., Walsh, T. J., Malech, H. L., & Holland, S. M. (2005). Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection. Clinical Infectious Diseases, 40(11), 1684–1688. https://doi.org/10.1086/430068

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free